Jichuan Pharmaceutical: Some directors and executives plan to reduce their holdings by no more than 181,000 shares.

Jichuan Pharmaceutical announced that due to personal funding needs, employee representative director Huang Qurong and Deputy General Manager and Chief Financial Officer Yan Hongquan plan to reduce their holdings of no more than 96,000 shares and 85,000 shares, respectively, through centralized bidding within three months after the 15 trading days following the announcement. Both reductions do not exceed 0.01% of the companys total share capital. This reduction plan will not have a significant impact on the company's governance and operations, and its implementation is subject to uncertainty.